Common Causes

The following infections are the most frequent culprits of a febrile illness described locally as “Nigerian fever.” Each can present with a similar pattern of high fever and systemic discomfort, but they differ in transmission, severity, and specific treatment.

• Malaria (Plasmodium falciparum) – Transmitted by Anopheles mosquitoes; the leading cause of fever in Nigeria.
• Dengue fever – Aedes mosquito‑borne viral infection; can progress to severe dengue.
• Lassa fever – Arenavirus spread by rodents; can cause hemorrhagic complications.
• Typhoid (Enteric fever) – Caused by Salmonella Typhi; spread via contaminated water/food.
• Yellow fever – Flavivirus transmitted by Aedes and Haemagogus mosquitoes; preventable by vaccination.
• Chikungunya – Another Aedes‑borne virus, notable for severe joint pain.
• Acute viral hepatitis (A, B, E) – Can present with fever, especially in early infection.
• Rickettsial infections (e.g., African tick bite fever) – Transmitted by ticks; cause fever with rash.
• Septicemia from bacterial infections – Commonly due to Staphylococcus, Streptococcus, or gram‑negative rods.
• COVID‑19 – Although global, it remains a relevant cause of fever in Nigeria.

Associated Symptoms

While fever is the hallmark, most patients experience additional signs that help narrow the cause.

• Headache – often frontal or retro‑orbital.
• Muscle and joint aches (myalgia, arthralgia).
• Chills and rigors.
• Fatigue and generalized weakness.
• Gastrointestinal upset – nausea, vomiting, diarrhea.
• Skin manifestations – rash (maculopapular, petechial), “sand‑paper” texture (dengue), or eschars (rickettsial).
• Respiratory symptoms – cough, sore throat (more common with COVID‑19 or atypical pneumonia).
• Abdominal pain – especially with typhoid or hepatitis.
• Bleeding tendencies – gum bleeding, hematuria, or melena (suggestive of severe dengue or Lassa).

When to See a Doctor

Fever itself is not always dangerous, but certain patterns signal a need for prompt medical evaluation.

• Fever persisting > 48 hours without improvement.
• Temperature ≥ 39.5 °C (103 °F) in an adult or any fever in infants < 3 months.
• Severe headache, neck stiffness, or confusion – possible meningitis.
• Persistent vomiting or inability to retain fluids.
• Blood in vomit, stool, or urine.
• Rapid heart rate (tachycardia) or low blood pressure (hypotension).
• New rash that spreads quickly or becomes bruised.
• Joint swelling or severe pain that limits movement.
• Recent travel to an area with known outbreaks (e.g., Lassa, yellow fever) without appropriate vaccination.
• Pregnancy – fevers can affect fetal development and require assessment.

Diagnosis

Because “Nigerian fever” encompasses many diseases, the diagnostic work‑up is systematic.

1. Clinical History & Physical Examination

• Onset, pattern, and duration of fever.
• Recent mosquito bites, exposure to rodents, travel, or known outbreaks.
• Vaccination history (yellow fever, hepatitis A/B).
• Review of systems to identify organ‑specific clues.

2. Laboratory Tests

• Complete blood count (CBC) – Anemia, leukopenia, or thrombocytopenia can point toward malaria, dengue, or Lassa.
• Rapid diagnostic tests (RDTs) for malaria, dengue NS1 antigen, and Lassa IgM/IgG.
• Blood cultures – Essential if bacterial sepsis is suspected.
• Serology / PCR for typhoid, yellow fever, chikungunya, and COVID‑19.
• Liver function tests (LFTs) – Elevated transaminases may indicate viral hepatitis or severe dengue.
• Renal panel – To detect dehydration or acute kidney injury.

3. Imaging (when indicated)

• Chest X‑ray – for pneumonia or pulmonary involvement.
• Abdominal ultrasound – in suspected hepatitis or organomegaly.

4. Specialty Tests

• Lumbar puncture – if meningitis is a concern.
• Peripheral smear (thick and thin) – gold‑standard for malaria parasites.

Treatment Options

Treatment hinges on identifying the underlying cause. Below are evidence‑based approaches for the most frequent etiologies.

1. Malaria

• First‑line: Artemisinin‑based combination therapy (e.g., artesunate‑amodiaquine, artemether‑lumefantrine) for P. falciparum infections (WHO, 2023).
• Severe malaria: Intravenous artesunate followed by oral ACT after clinical stabilization.
• Supportive care – antipyretics, rehydration, and monitoring for complications (cerebral malaria, anemia).

2. Dengue Fever

• No specific antiviral; management is supportive.
• Fluid replacement guided by hematocrit and clinical status – avoid over‑hydration.
• Acetaminophen for fever and pain (avoid NSAIDs/aspirin due to bleeding risk).
• Hospitalization for warning signs (severe abdominal pain, persistent vomiting, mucosal bleeding).

3. Lassa Fever

• Ribavirin (started early, within 6 days of symptom onset) improves survival (NIH, 2022).
• Strict isolation and use of personal protective equipment (PPE) to prevent nosocomial spread.
• Supportive care: fluid/electrolyte balance, blood product transfusion if hemorrhage occurs.

4. Typhoid Fever

• Empiric oral fluoroquinolone (e.g., ciprofloxacin) or third‑generation cephalosporin (ceftriaxone) pending culture results.
• Resistance patterns in Nigeria increasingly show fluoroquinolone resistance – sensitivity testing is essential.
• Hydration and antipyretics as needed.

5. Yellow Fever

• No antiviral; care is supportive (fluid management, treat co‑infections).
• Vaccination is the primary preventive measure; post‑exposure prophylaxis is not available.

6. General Symptomatic Relief (All Causes)

• Antipyretics – acetaminophen up to 1 g every 6 hours (max 4 g/day).
• Hydration – oral rehydration solutions (ORS) or IV fluids if unable to tolerate orally.
• Rest and a balanced diet once appetite returns.

7. When a Specific Pathogen Is Not Identified

Empiric broad‑spectrum antibiotics (e.g., ceftriaxone) may be started in severely ill patients while awaiting results, especially when bacterial sepsis cannot be ruled out. De‑escalation should follow laboratory data.

Prevention Tips

Because many of the underlying infections are vector‑borne or related to sanitation, prevention focuses on environmental control and personal protective measures.

• Use insecticide‑treated bed nets and screen windows/doors to reduce mosquito bites.
• Apply EPA‑registered repellents containing DEET, picaridin, or oil of lemon eucalyptus.
• Wear long‑sleeved clothing and trousers during peak mosquito activity (dusk‑dawn).
• Eliminate standing water around homes to limit mosquito breeding sites.
• Maintain good food and water hygiene – boil or treat water, wash fruits/vegetables, avoid street‑food from dubious sources.
• Get vaccinated where vaccines exist: yellow fever, hepatitis A/B, typhoid oral vaccine, and COVID‑19.
• Practice rodent control: store food in sealed containers, keep surroundings clean, and use traps when necessary.
• Seek prompt medical care for any febrile illness after travel to high‑risk regions.
• Educate community members about early symptom recognition and the importance of completing full courses of prescribed medication.

Emergency Warning Signs

Key Take‑aways

• “Nigerian fever” is a descriptive term for several acute febrile illnesses common in Nigeria.
• The most frequent causes include malaria, dengue, Lassa fever, typhoid, and yellow fever.
• Prompt medical evaluation is essential when fever is high, prolonged, or accompanied by warning signs.
• Accurate diagnosis relies on a combination of history, physical exam, rapid tests, and laboratory studies.
• Treatment is pathogen‑specific; many infections are curable (malaria, typhoid, Lassa) while others require supportive care (dengue, yellow fever).
• Prevention hinges on vector control, safe water/food practices, and appropriate vaccinations.
• Recognize emergency red flags and act quickly to reduce the risk of severe complications or death.

For the most up‑to‑date recommendations, consult reputable sources such as the CDC, WHO, Mayo Clinic, and the NIH.